Sign In

Kiersten Stead

Managing Partner DCVC Bio

Dr. Kiersten Stead is a prominent figure in the venture capital and biotechnology sectors, serving as a Managing Partner at DCVC Bio, a venture capital firm focused on early-stage deep-tech startups in life sciences. Her expertise spans therapeutics, agriculture, and industrial biotechnology, leveraging computational advantages to drive innovation in these fields.123

Background and Education

  • Ph.D. in Molecular Biology & Genetics: Dr. Stead holds a Ph.D. in Molecular Biology & Genetics from the University of Alberta.14
  • MBA in Finance: She also holds an MBA in Finance from the University of Alberta, where she was an AHFMR Scholar.4

Career Highlights

  • Scientist and Entrepreneur: Before joining DCVC Bio, Dr. Stead was a scientist and co-founded several life-science companies. She has over 15 years of experience in the biotechnology industry.14
  • Investment Director at Monsanto Growth Ventures (MGV): Prior to DCVC Bio, she was an Investment Director at MGV, which was a leading investor in agriculture globally.34
  • Burrill & Company Venture Team: She was part of this team, investing broadly in life sciences and industrial biotechnology.4

Investments and Board Roles

  • Lead Investor: Dr. Stead has led investments in companies like Abcellera, Blue River Technology, Umoja, Mycoworks, Novome, and Plexium.2
  • Board Memberships: She serves on the boards of several companies, including Mycoworks, Creyon Bio, and Novome Biotechnologies.5 Additionally, she is involved with not-for-profit organizations such as the Danforth Center for Plant Sciences and the Keystone Symposia SAB.1

LinkedIn Profile

While the specific LinkedIn username provided does not match the publicly available information, Dr. Stead's professional profile highlights her role as a Managing Partner at DCVC Bio and her extensive experience in biotechnology and venture capital.

Conclusion

Dr. Kiersten Stead is a seasoned scientist-investor with a strong background in molecular biology and finance. Her work at DCVC Bio focuses on supporting deep-tech startups that leverage computational biology to solve significant challenges in life sciences.

Highlights

Jan 6 · techcrunch.com
Kiersten Stead, Author at TechCrunch
Kiersten Stead, Author at TechCrunch
Kiersten Stead - SXSW 2019 Schedule
Oct 7 · dcvc.com
DCVC Bio
Oct 1 · dcvc.com
DCVC | Home
Jul 18 · dcvc.com
Managing Partner, DCVC Bio - Dr. Kiersten Stead
Managing Partner, DCVC Bio - Dr. Kiersten Stead
Dec 9 · vcsheet.com
Dr. Kiersten Stead (DCVC) / VC Breakdown & Contact - VC Sheet
Aug 7 · Eminetra
Former Hermès CEO Patrick Thomas joins US synthetic leather maker MycoWorks - Eminetra
Ex-Hermès CEO Patrick Thomas joins US' faux leather maker MycoWorks - Fibre2fashion.com
Kiersten Stead - SynBioBeta 2018

Related Questions

What are some of the companies Kiersten Stead has invested in?
How did Kiersten Stead transition from being a scientist to a venture capitalist?
What are the main focus areas for DCVC Bio under Kiersten Stead's leadership?
Can you provide examples of successful investments made by Kiersten Stead?
What is Kiersten Stead's educational background and how has it influenced her career?
Kiersten Stead
Kiersten Stead, photo 1
Kiersten Stead, photo 2
Add to my network

Location

San Francisco, California